UProf. Zhang Naisong
Udokotela Oyinhloko
Ilungu lekomidi lochwepheshe lokuhlinzwa kwekhanda nentamo le-China Anti-Cancer Association. Ibhodi lokuhlela le-Chinese Journal of Otorhinolaryngology-ukuhlinzwa kwekhanda nentamo, i-Chinese Journal of clinicians, kanye namanye amaphephabhuku ezokwelapha.
Ubuchwepheshe Bezokwelapha
Manje usebenza ekuhlinzeni ikhanda nentamo eBeijing Cancer Hospital. Usebe yingxenye yokuhlinzwa kwesifo sekhanda nentamo iminyaka engama-30 futhi uqoqe ulwazi olucebile lwezokwelapha. Uqede cishe ukuhlinzwa okungu-10,000 kuzo zonke izinhlobo zezimila zekhanda nentamo, futhi muhle kuzo zonke izinhlobo zokwelashwa kokuhlinzwa kwezimila zekhanda nentamo, ikakhulukazi izimila ezinobungozi ze-thyroid. Ukwelashwa kwezinhlobo ezahlukene zomdlavuza we-laryngeal kunesifundo esijulile, ukuze izehlakalo zezinkinga ekuhlinzeni kwe-thyroid zehle zibe ngu-0.1%, kanti izinga lokusinda kweminyaka eyi-10 lomdlavuza we-thyroid lingaphezu kuka-90%. Izinga lokusinda kweminyaka emi-5 lomdlavuza we-laryngeal lingu-75%, kanti ama-70% eziguli ezinomdlavuza we-laryngeal angalulama ekusebenzeni kwawo kokuphefumula nokukhuluma ngemva kokususwa. Ingenza ngobuchule ukulungisa nokwakha kabusha iziphambeko ezahlukene ngemva kokususwa kwezimila zomlomo neze-maxillofacial (njengomdlavuza wolimi, umdlavuza waphansi komlomo, isimila se-maxillary ne-mandible, umdlavuza wezindebe, i-buccal mucosa, njll.). Amaphepha ezokwelapha angaphezu kuka-30 ashicilelwe emaphephandabeni kazwelonke ayinhloko. Njengoba ukwanda kokusetshenziswa kokwelashwa okuphelele komdlavuza wekhanda nentamo othuthukile, ikhwalithi yokuphila kanye nezinga lokusinda kweziguli ezinomdlavuza wekhanda nentamo kuye kwathuthukiswa kakhulu.
Unekhono kuzo zonke izinhlobo zokwelapha ngokuhlinzwa izimila zekhanda nentamo, ikakhulukazi izimila ezinobungozi ze-thyroid kanye nezinhlobo ezahlukene zomdlavuza we-laryngeal.
Isikhathi sokuthunyelwe: Mashi-04-2023